Compare Cronos Group Inc (CRON) vs Robinhood Markets, Inc. (HOOD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Robinhood Markets, Inc. — how do they compare? Cronos Group Inc trades at $3.22 (market cap $1.18B), while Robinhood Markets, Inc. trades at $108.3 (market cap $96.21B). The key difference: Robinhood Markets, Inc. is far larger — about 81.5× Cronos Group Inc's market cap, and Cronos Group Inc is trading nearer its 52-week high, Robinhood Markets, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Robinhood Markets, Inc. for 75 Days on average.
| CRON | HOOD | |
|---|---|---|
Market Cap | $1.18B | $96.21B |
Volume | 968,037 | 22,572,153 |
Sector | Health | Financials |
52-Week High | $3.55 | $152.46 |
52-Week Low | $2.30 | $65.16 |
Typical Hold Time | 22 Days | 75 Days |
Enterprise Value | $387.62M | $102.75B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.24, down 1.37% today amid a bearish technical signal. Recent quarterly earnings show beats in Q1 and Q2 2026, with revenue growth from $118M in 2024 to $147M in 2025. The company reported a net loss of $9.45M in 2025 but projects a profit of $70M for 2026. Analyst sentiment is mixed with a 20% buy rating. News highlights focus on international expansion and a recent Investor Day outlining growth strategies.
Outlook is cautiously optimistic given projected profitability in 2026 and strong cash reserves, but risks include sustained negative cash flow and competitive pressures. The stock's valuation metrics like P/E of 16.95 and P/S of 6.84 suggest moderate pricing relative to peers, though high EV/EBITDA of 43 indicates premium expectations.
Robinhood (HOOD) trades at $109.51, down 2.22% on the day, with a bullish technical signal and strong support at $108. The company reported robust 2025 results with $4.47B revenue and $1.88B net income, though valuation ratios like a P/E of 47.35 remain elevated. Recent news highlights expansion into 24/7 stock trading and AI-powered features, signaling growth initiatives.
Outlook is positive with a $137 consensus price target and 77% buy ratings, but high valuation and competitive pressures pose risks. Earnings beat in Q2 2026 and upcoming Q3 results on October 27, 2026, are key catalysts, though regulatory scrutiny and market volatility could impact momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Robinhood Markets, Inc.
Robinhood Markets, Inc. operates a financial services platform. The Company offers brokerage and cash management applications such as stocks, exchange-traded funds, options, and cryptocurrency. Robinhood Markets serves clients in the United States.
Read more on HOOD →
